Joel Beatty
Stock Analyst at Baird
(4.2)
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
DNTH Dianthus Therapeutic... | Maintains: Outperform | 50 67 | 37.86 | 76.97% | 3 | Sep 9, 2025 | |
EDIT Editas Medicine | Maintains: Outperform | 4 6 | 2.71 | 121.4% | 5 | Aug 13, 2025 | |
COGT Cogent Biosciences | Maintains: Neutral | 7 9 | 12.81 | -29.74% | 6 | Jul 8, 2025 | |
SAGE Sage Therapeutics | Maintains: Neutral | 7 9 | 8.68 | 3.69% | 5 | Jun 20, 2025 | |
ELF e.l.f. Beauty | Maintains: Outperform | 110 145 | 138 | 5.07% | 7 | Jun 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 28 31 | 24.2 | 28.1% | 4 | May 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 38 24 | 20.08 | 19.52% | 5 | May 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 680 680 | 763.49 | -10.94% | 7 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 29 | 14.82 | 95.68% | 2 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 70 66 | 60.96 | 8.27% | 15 | May 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 167 155 | 128.46 | 20.66% | 4 | May 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 160 162 | 122.96 | 31.75% | 5 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 38 41 | 27.71 | 47.96% | 3 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 10 | 4.17 | 139.81% | 2 | Mar 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 27 16 | 9.65 | 65.8% | 2 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 16 | 11.81 | 35.48% | 2 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 117 73 | 39.42 | 85.19% | 2 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 28 32 | 20.25 | 58.02% | 2 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 75 | 49.38 | 51.88% | 1 | Nov 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 3 11 | 11.84 | -7.09% | 4 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 7 | 1.66 | 321.69% | 5 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 72 65 | 55.91 | 16.26% | 5 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 112 127 | 129.46 | -1.9% | 3 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 36 60 | n/a | n/a | 2 | Jul 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 68 72 | 31.23 | 130.55% | 4 | May 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 540 240 | 1.62 | 14714.81% | 3 | May 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 5 | 1.32 | 240.91% | 2 | Apr 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 83 103 | 131.87 | -21.89% | 2 | Apr 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 25 | 9.2 | 171.74% | 3 | Apr 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 11 9 | n/a | n/a | 2 | Mar 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 | 28 | 0% | 3 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 28 | 16.37 | 71.04% | 2 | Oct 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | n/a | n/a | 1 | Sep 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 140 60 | n/a | n/a | 3 | Aug 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 16 | 1.97 | 712.18% | 1 | Jun 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | 8.54 | -18.03% | 1 | May 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 4 2 | 1.87 | -33.16% | 2 | May 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 44 | 1.65 | 2566.67% | 3 | Apr 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 58 | 29.72 | 95.15% | 6 | Feb 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 24 | 24.93 | -3.73% | 2 | Nov 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 18 | 18.04 | -0.22% | 3 | Nov 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 6 | 2.08 | 188.46% | 2 | Aug 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 46 31 | 1.27 | 2340.94% | 3 | Jun 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 36 28 | 5.23 | 435.37% | 2 | Mar 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 170 175 | 468.58 | -62.65% | 2 | Feb 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 | 4.6 | 204.35% | 8 | Jan 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 108 | 17.91 | 503.02% | 7 | Jan 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 74 | n/a | n/a | 2 | Oct 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 78 | 64.04 | 21.8% | 3 | Aug 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 440 160 | n/a | n/a | 2 | Jun 11, 2020 |